Congenital lipoid adrenal hyperplasia

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Congenital lipoid adrenal hyperplasia (lipoid CAH) is a severe, often fatal, genetic disorder affecting adrenal and gonadal steroidogenesis.
• Mutations in the steroidogenic acute regulatory protein (StAR) gene are the most common cause, leading to adrenal failure and impaired sexual development in 46,XY individuals.
• The StAR p.Q258X mutation is particularly prevalent in Japanese and Korean populations.

Purpose of the Study:

• To summarize the genetic causes and clinical spectrum of congenital lipoid adrenal hyperplasia.
• To highlight the recognition of 'nonclassic lipoid CAH' with late and mild clinical presentations.
• To introduce mutations in the P450scc (CYP11A1) gene as another cause of lipoid CAH.

Main Methods:

• Review of existing literature on lipoid CAH.
• Analysis of genetic mutations in StAR and CYP11A1 genes.
• Clinical case study review for nonclassic presentations.

Main Results:

• Lipoid CAH is primarily caused by recessive StAR mutations, with a specific mutation dominating in certain Asian populations.
• A subset of patients presents with nonclassic lipoid CAH, characterized by delayed and less severe symptoms.
• Mutations in the cholesterol side-chain cleavage enzyme (P450scc/CYP11A1) have recently been identified as a cause of lipoid CAH.

Conclusions:

• Lipoid CAH results from defects in key steroidogenic enzymes, primarily StAR and now recognized to include CYP11A1.
• The identification of nonclassic forms broadens the diagnostic scope and understanding of lipoid CAH.
• Recognizing P450scc mutations expands the genetic basis of this critical human endocrine disorder.